New insights on the role of connexins and Gap Junctions Channels in adipose tissue and Obesity

datacite.rightshttp://purl.org/coar/access_right/c_abf2eng
dc.contributor.authorGonzález-Casanova, Jorge Enrique
dc.contributor.authorDurán-Agüero, Samuel
dc.contributor.authorCaro-Fuentes, Nelson Javier
dc.contributor.authorGamboa-Arancibia, Maria Elena
dc.contributor.authorTamara, Bruna
dc.contributor.authorBermúdez, Valmore
dc.contributor.authorRojas-Gómez, Diana Marcela
dc.date.accessioned2023-08-19T20:13:30Z
dc.date.available2023-08-19T20:13:30Z
dc.date.issued2021
dc.description.abstractDue to the inability to curb the excessive increase in the prevalence of obesity and overweight, it is necessary to comprehend in more detail the factors involved in the pathophysiology and to appreciate more clearly the biochemical and molecular mechanisms of obesity. Thus, understanding the biological regulation of adipose tissue is of fundamental relevance. Connexin, a protein that forms intercellular membrane channels of gap junctions and unopposed hemichannels, plays a key role in adipogenesis and in the maintenance of adipose tissue homeostasis. The expression and function of Connexin 43 (Cx43) during the different stages of the adipogenesis are differentially regulated. Moreover, it has been shown that cell–cell communication decreases dramatically upon differentiation into adipocytes. Furthermore, inhibition of Cx43 degradation or constitutive overexpression of Cx43 blocks adipocyte differentiation. In the first events of adipogenesis, the connexin is highly phosphorylated, which is likely associated with enhanced Gap Junction (GJ) communication. In an intermediate state of adipocyte differentiation, Cx43 phosphorylation decreases, as it is displaced from the membrane and degraded through the proteasome; thus, Cx43 total protein is reduced. Cx is involved in cardiac disease as well as in obesity-related cardiovascular diseases. Different studies suggest that obesity together with a high-fat diet are related to the production of remodeling factors associated with expression and distribution of Cx43 in the atrium.eng
dc.format.mimetypepdfeng
dc.identifier.citationGonzález-Casanova, J.E.; Durán-Agüero, S.; Caro-Fuentes, N.J.; Gamboa-Arancibia, M.E.; Bruna, T.; Bermúdez, V.; Rojas-Gómez, D.M. New Insights on the Role of Connexins and Gap Junctions Channels in Adipose Tissue and Obesity. Int. J. Mol. Sci. 2021, 22, 12145. https://doi.org/10.3390/ijms222212145eng
dc.identifier.doihttps://doi.org/10.3390/ijms222212145
dc.identifier.issn14220067
dc.identifier.urihttps://hdl.handle.net/20.500.12442/13166
dc.language.isoengeng
dc.publisherMDPIeng
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.accessrightsinfo:eu-repo/semantics/openAccesseng
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceInternational Journal of Molecular Scienceseng
dc.sourceVol. 20 Issue 22 (2021)eng
dc.subjectConnexinseng
dc.subjectGap junctions channelseng
dc.subjectAdipose tissueeng
dc.subjectObesityeng
dc.subjectCardiovascular diseaseseng
dc.titleNew insights on the role of connexins and Gap Junctions Channels in adipose tissue and Obesityeng
dc.type.driverinfo:eu-repo/semantics/articleeng
dc.type.spaArtículo científicospa
dcterms.referencesArroyo-Johnson, C.; Mincey, K.D. Obesity epidemiology worldwide. Gastroenterol. Clin. N. Am. 2017, 45, 571–579. [Google Scholareng
dcterms.referencesMello, M.M. Obesity—Personal choice or public health issue? Nat. Clin. Pract. Endocrinol. Metab. 2008, 4, 2–3. [Google Scholareng
dcterms.referencesGadde, K.M.; Martin, C.K.; Berthoud, H.R.; Heymsfield, S.B. Obesity: Pathophysiology and management. J. Am. Coll. Cardiol. 2018, 71, 69–84.eng
dcterms.referencesLongo, M.; Zatterale, F.; Naderi, J.; Parrillo, L.; Formisano, P.; Raciti, G.A.; Beguinot, F.; Miele, C. Adipose tissue dysfunction as determinant of obesity-associated metabolic complications. Int. J. Mol. Sci. 2019, 20, 2358.eng
dcterms.referencesPellegrinelli, V.; Carobbio, S.; Vidal-Puig, A. Adipose tissue plasticity: How fat depots respond differently to pathophysiological cues. Diabetologia 2016, 59, 1075–1088.eng
dcterms.referencesSchulz, T.J.; Tseng, Y.H. Brown adipose tissue: Development, metabolism and beyond. Biochem. J. 2013, 453, 167–178. [Google Scholar]eng
dcterms.referencesChazenbalk, G.; Bertolotto, C.; Heneidi, S.; Jumabay, M.; Trivax, B.; Aronowitz, J.; Yoshimura, K.; Simmons, C.F.; Dumesic, D.A.; Azziz, R. Novel pathway of adipogenesis through cross-talk between adipose tissue macrophages, adipose stem cells and adipocytes: Evidence of cell plasticity. PLoS ONE 2011, 6, 17834.eng
dcterms.referencesGhaben, A.L.; Scherer, P.E. Adipogenesis and metabolic health. Nat. Rev. Mol. Cell Biol. 2019, 20, 242–258.eng
dcterms.referencesVishvanath, L.; Gupta, R.K. Contribution of adipogenesis to healthy adipose tissue expansion in obesity. J. Clin. Investig. 2019, 129, 4022–4031.eng
dcterms.referencesAmbele, M.A.; Dhanraj, P.; Giles, R.; Pepper, M.S. Adipogenesis: A complex interplay of multiple molecular determinants and pathways. Int. J. Mol. Sci. 2020, 21, 4283.eng
dcterms.referencesSarantopoulos, C.N.; Banyard, D.A.; Ziegler, M.E.; Sun, B.; Shaterian, A.; Widgerow, A.D. Elucidating the preadipocyte and its role in adipocyte formation: A comprehensive review. Stem Cell Rev. Rep. 2018, 14, 27–42.eng
dcterms.referencesMota de Sá, P.; Richard, A.J.; Hang, H.; Stephens, J.M. Transcriptional regulation of adipogenesis adipose tissue: A dynamic organ. Compr. Physiol. 2017, 7, 635–674. [eng
dcterms.referencesGray, S.L.; Dalla Nora, E.; Vidal-Puig, A.J. Mouse models of PPAR-γ deficiency: Dissecting PPAR-γ’s role in metabolic homoeostasis. Biochem. Soc. Trans. 2005, 33, 1053–1058.Kroon, T.; Harms, M.; Maurer, S.; Bonnet, L.; Alexandersson, I.; Lindblom, A.; Ahnmark, A.; Nilsson, D.; Gennemark, P.; O’Mahony, G.; et al. PPARγ and PPARα synergize to induce robust browning of white fat in vivo. Mol. Metab. 2020, 36, 1–14.eng
dcterms.referencesFarmer, S.R. Regulation of PPAR gamma activity during adipogenesis. Int. J. Obes. 2005, 29, 13–16.eng
dcterms.referencesTontonoz, P.; Hu, E.; Graves, R.A.; Budavari, A.I.; Spiegelman, B.M. mPPAR gamma 2: Tissue-specific regulator of an adipocyte enhancer. Genes Dev. 1994, 4, 1224–1234.eng
dcterms.referencesPayne, V.; Au, W.S.; Lowe, C.; Rahman, S.; Friedman, J.; O’Rahilly, S.; Rochford, J.J. C/EBP transcription factors regulate SREBP1c gene expression during adipogenesis. Biochem. J. 2010, 425, 215–223. [Googleeng
dcterms.referencesTong, Q.; Dalgin, G.; Xu, H.; Ting, C.; Leiden, J.M.; Hotamisligil, G.S. Function of GATA transcription factors in preadipocyte—Adipocyte transition. Science 2000, 290, 134–138.eng
dcterms.referencesTong, Q.; Tsai, J.; Tan, G.; Dalgin, G.; Hotamisligil, G.S. Interaction between GATA and the C / EBP family of transcription factors is critical in GATA-mediated suppression of adipocyte differentiation. Mol. Cell. Biol. 2005, 25, 706–715.eng
dcterms.referencesJack, B.H.A.; Crossley, M. GATA proteins work together with friend of GATA (FOG) and C-terminal binding protein (CTBP) co-regulators to control. J. Biol. Chem. 2010, 285, 32405–32414.eng
dcterms.referencesRoss, S.E.; Hemati, N.; Longo, K.A.; Bennett, C.N.; Lucas, P.C.; Erickson, R.L.; MacDougald, O.A. Inhibition of adipogenesis by WNT signaling. Science 2000, 289, 950–954.eng
dcterms.referencesAl-Mansoori, L.; Al-Jaber, H.; Madani, A.Y.; Mazloum, N.A.; Agouni, A.; Ramanjaneya, M.; Abou-Samra, A.B.; Elrayess, M.A. Suppression of GATA-3 increases adipogenesis, reduces inflammation and improves insulin sensitivity in 3T3L-1 preadipocytes. Cell. Signal. 2020, 75, 109735.eng
dcterms.referencesChristodoulides, C.; Lagathu, C.; Sethi, J.K.; Vidal, A. Adipogenesis and WNT signalling. Trends Endocrinol. Metab. 2009, 20, 16–24. [eng
dcterms.referencesBennett, C.N.; Ross, S.E.; Longo, K.A.; Bajnok, L.; Hemati, N.; Johnson, K.W.; Harrison, S.D.; Macdougald, O.A. Regulation of WNT signaling during Adipogenesis. J. Biol. Chem. 2002, 277, 30998–31004.eng
dcterms.referencesRevel, J.P.; Karnovsky, M. Hexagonal array of subunits in intercellular junctions of the mouse heart and liver. J. Cell Biol. 1967, 33, 7–12.eng
dcterms.referencesXu, Q.; Kopp, R.F.; Chen, Y.; Yang, J.J.; Roe, M.W.; Veenstra, R.D. Gating of connexin 43 gap junctions by a cytoplasmic loop calmodulin binding domain. Am. J. Physiol. Physiol. 2012, 302, c1548–c1556.eng
dcterms.referencesGoodenough, D.A.; Paul, D.L. Gap junctions. Cold Spring Harb. Perspect. Biol. 2009, 1, a002576.eng
dcterms.referencesBeyer, E.C.; Paul, D.L.; Goodenough, D.A. Connexin 43: A protein from rat heart homologous to a gap junction protein from liver. J. Cell Biol. 1987, 105, 2621–2629eng
dcterms.referencesOshima, A. Structure and closure of connexin gap junction channels. FEBS Lett. 2014, 588, 1230–1237.eng
dcterms.referencesNielsen, M.S.; Axelsen, L.N.; Sorgen, P.L.; Verma, V.; Delmar, M.; Holstein-Rathlou, N.H. Gap junctions. Compr. Physiol. 2012, 2, 1981–2035.eng
dcterms.referencesPaul, D. Molecular cloning of CDNA for rat liver gap junction protein. J. Cell Biol. 1986, 103, 123–134. [Googleeng
dcterms.referencesBeyer, E.C.; Berthoud, V.M. Gap junction gene and protein families: Connexins, innexins, and pannexins. Biochim. Biophys. Acta 2018, 1860, 5–8. [eng
dcterms.referencesHoughton, F.D. Role of gap junctions during early embryo development. Reproduction 2005, 129, 129–135.eng
dcterms.referencesMontgomery, J.; Richardson, W.J.; Marsh, S.; Rhett, J.M.; Bustos, F.; Degen, K.; Ghatnekar, G.S.; Grek, C.L.; Jourdan, L.J.; Holmes, J.W.; et al. The connexin 43 carboxyl terminal mimetic peptide ACT1 prompts differentiation of a collagen scar matrix in humans resembling unwounded skin. FASEB J. 2021, 35, e21762.eng
dcterms.referencesBennett, M.V.L.; Zukin, R.S. Neuronal synchronization in the mammalian brain. Neuron 2004, 41, 495–511eng
dcterms.referencesGarcía, I.E.; Prado, P.; Pupo, A.; Jara, O.; Rojas-Gómez, D.; Mujica, P.; Flores-Muñoz, C.; González-Casanova, J.; Soto-Riveros, C.; Pinto, B.I.; et al. Connexinopathies: A structural and functional glimpse. BMC Cell Biol. 2016, 17, 71–87. [eng
dcterms.referencesKim, E.Y.; Jun, K.H.; Yim, K. The roles of connexin 26, 32, and 43 as prognostic factors for gastric cancer. Anticancer Res. 2020, 40, 4537–4545eng
dcterms.referencesFukuyama, K.; Fukuzawa, M.; Okubo, R.; Okada, M. Upregulated connexin 43 induced by loss-of-functional S284L-mutant α 4 subunit of nicotinic ACh receptor contributes to pathomechanisms of autosomal dominant sleep-related hypermotor epilepsy. Pharmaceuticals 2020, 13, 58.eng
dcterms.referencesRamadan, R.; Baatout, S.; Aerts, A.; Leybaert, L. The role of connexin proteins and their channels in radiation—Induced atherosclerosis. Cell. Mol. Life Sci. 2021, 78, 3087–3103.eng
dcterms.referencesSevers, N.J.; Bruce, A.F.; Dupont, E.; Rothery, S. Remodelling of gap junctions and connexin expression in diseased myocardium. Cardiovasc. Res. 2008, 80, 9–19.eng
dcterms.referencesHarris, A.L. Connexin channel permeability to cytoplasmic molecules. Prog. Biophys. Mol. Biol. 2007, 94, 120–143.eng
dcterms.referencesChen, V.C.; Gouw, J.W.; Naus, C.C.; Foster, L.J. Connexin multi-site phosphorylation: Mass spectrometry-based proteomics fills the gap. Biochim. Biophys. Acta 2013, 1828, 23–34eng
dcterms.referencesMoreno, A.P. Connexin phosphorylation as a regulatory event linked to channel gating. Biochim. Biophys. Acta 2005, 1711, 164–171.eng
dcterms.referencesSun, Z.; Yang, Y.; Wu, L.; Talabieke, S.; You, H.; Zheng, Y.; Luo, D. Connexin 43-serine 282 modulates serine 279 phosphorylation in cardiomyocytes. Biochem. Biophys. Res. Commun. 2019, 513, 567–572.eng
dcterms.referencesLampe, P.D.; Lau, A.F. Regulation of gap junctions by phosphorylation of connexins. Arch. Biochem. Biophys. 2000, 384, 5–15.eng
dcterms.referencesBao, X.; Reuss, L.; Altenberg, G.A. Regulation of purified and reconstituted connexin 43 hemichannels by protein kinase C-mediated phosphorylation of Serine 368. J. Biol. Chem. 2004, 279, 20058–20066.eng
dcterms.referencesLastwika, K.J.; Dunn, C.A.; Solan, J.L.; Lampe, P.D. Phosphorylation of connexin 43 at MAPK, PKC or CK1 sites each distinctly alter the kinetics of epidermal wound repair. J. Cell Sci. 2019, 132, jcs234633eng
dcterms.referencesEgan Benova, T.; Viczenczova, C.; Szeiffova Bacova, B.; Knezl, V.; Dosenko, V.; Rauchova, H.; Zeman, M.; Reiter, R.J.; Tribulova, N. Obesity-associated alterations in cardiac connexin-43 and PKC signaling are attenuated by melatonin and omega-3 fatty acids in female rats. Mol. Cell. Biochem. 2019, 454, 191–202eng
dcterms.referencesDunn, C.A.; Su, V.; Lau, A.F.; Lampe, P.D. Activation of Akt, not connexin 43 protein ubiquitination, regulates gap junction stability. J. Biol. Chem. 2012, 287, 2600–2607eng
dcterms.referencesDunn, C.A.; Su, V.; Lau, A.F.; Lampe, P.D. Activation of Akt, not connexin 43 protein ubiquitination, regulates gap junction stability. J. Biol. Chem. 2012, 287, 2600–2607.eng
dcterms.referencesDunn, C.A.; Lampe, P.D. Injury-triggered Akt phosphorylation of Cx43: A ZO-1-driven molecular switch that regulates gap junction size. J. Cell Sci. 2014, 127, 455–464.eng
dcterms.referencesSorgen, P.L.; Trease, A.J.; Spagnol, G.; Delmar, M.; Nielsen, M.S. Protein-protein interactions with connexin 43: Regulation and function. Int. J. Mol. Sci. 2018, 19, 1428.eng
dcterms.referencesSáez, J.C.; Nairn, A.C.; Czernik, A.J.; Spray, D.C.; Hertzberg, E.L.; Greengard, P.; Bennett, M.V. Phosphorylation of connexin 32, a hepatocyte gap-junction protein, by cAMP-dependent protein kinase, protein kinase C and Ca2+/calmodulin-dependent protein kinase II. Eur. J. Biochem. 1990, 192, 263–273eng
dcterms.referencesPeracchia, C. Calmodulin-mediated regulation of gap junction channels. Int. J. Mol. Sci. 2020, 21, 485. [eng
dcterms.referencesZou, J.; Salarian, M.; Chen, Y.; Veenstra, R.; Louis, C.F.; Yang, J.J. Gap junction regulation by calmodulin. FEBS Lett. 2014, 588, 1430–1438.eng
dcterms.referencesJohnstone, S.R.; Kroncke, B.M.; Straub, A.C.; Best, A.K.; Dunn, C.A.; Mitchell, L.A.; Peskova, Y.; Nakamoto, R.K.; Koval, M.; Lo, C.W.; et al. MAPK phosphorylation of connexin 43 promotes binding of cyclin E and smooth muscle cell proliferation. Circ. Res. 2012, 111, 201–211. [eng
dcterms.referencesChandrasekhar, A.; Bera, A.K. Hemichannels: Permeants and their effect on development, physiology and death. Cell Biochem. Funct. 2012, 30, 89–100eng
dcterms.referencesChandrasekhar, A.; Bera, A.K. Hemichannels: Permeants and their effect on development, physiology and death. Cell Biochem. Funct. 2012, 30, 89–100eng
dcterms.referencesBennett, M.V.; Contreras, J.E.; Bukauskas, F.F.; Sáez, J.C. New roles for astrocytes: Gap junction hemichannels have something to communicate. Trends Neurosci. 2003, 26, 610–617.eng
dcterms.referencesSáez, J.C.; Retamal, M.A.; Basilio, D.; Bukauskas, F.F.; Bennett, M.V. Connexin-based gap junction hemichannels: Gating mechanisms. Biochim. Biophys. Acta 2005, 1711, 215–224.eng
dcterms.referencesSáez, J.C.; Schalper, K.A.; Retamal, M.A.; Orellana, J.A.; Shoji, K.F.; Bennett, M.V. Cell membrane permeabilization via connexin hemichannels in living and dying cells. Exp. Cell Res. 2010, 316, 2377–238eng
dcterms.referencesContreras, J.E.; Sánchez, H.A.; Véliz, L.P.; Bukauskas, F.F.; Bennett, M.V.; Sáez, J.C. Role of connexin-based gap junction channels and hemichannels in ischemia-induced cell death in nervous tissue. Brain Res. Rev. 2004, 47, 290–303eng
dcterms.referencesCherian, P.P.; Siller-Jackson, A.J.; Gu, S.; Wang, X.; Bonewald, L.F.; Sprague, E.; Jiang, J.X. Mechanical strain opens connexin 43 hemichannels in osteocytes: A novel mechanism for the release of prostaglandin. Mol. Biol. Cell 2005, 16, 3100–3106eng
dcterms.referencesRetamal, M.A.; Cortés, C.J.; Reuss, L.; Bennett, M.V.; Sáez, J.C. S-nitrosylation and permeation through connexin 43 hemichannels in astrocytes: Induction by oxidant stress and reversal by reducing agents. Proc. Natl. Acad. Sci. USA 2006, 103, 4475–4480.eng
dcterms.referencesRetamal, M.A.; Schalper, K.A.; Shoji, K.F.; Bennett, M.V.; Sáez, J.C. Opening of connexin 43 hemichannels is increased by lowering intracellular redox potential. Proc. Natl. Acad. Sci. USA 2007, 104, 8322–8327. [eng
dcterms.referencesRetamal, M.A. Connexin and Pannexin hemichannels are regulated by redox potential. Front. Physiol. 2014, 5, 80eng
dcterms.referencesMugisho, O.O.; Green, C.R.; Kho, D.T.; Zhang, J.; Graham, E.S.; Acosta, M.L.; Rupenthal, I.D. The inflammasome pathway is amplified and perpetuated in an autocrine manner through connexin43 hemichannel mediated ATP release. Biochim. Biophys. Acta Gen. Subj. 2018, 1862, 385–393.eng
dcterms.referencesBennett, M.V.; Garré, J.M.; Orellana, J.A.; Bukauskas, F.F.; Nedergaard, M.; Sáez, J.C. Connexin and pannexin hemichannels in inflammatory responses of glia and neurons. Brain Res. 2012, 1487, 3–15eng
dcterms.referencesGonzález-Casanova, J.; Schmachtenberg, O.; Martínez, A.D.; Sanchez, H.A.; Harcha, P.A.; Rojas-Gomez, D. An update on connexin gap junction and hemichannels in diabetic retinopathy. Int. J. Mol. Sci. 2021, 22, 3194eng
dcterms.referencesCotrina, M.L.; Lin, J.H.; Alves-Rodrigues, A.; Liu, S.; Li, J.; Azmi-Ghadimi, H.; Kang, J.; Naus, C.C.; Nedergaard, M. Connexins regulate calcium signaling by controlling ATP release. Proc. Natl. Acad. Sci. USA 1998, 95, 15735–15740eng
dcterms.referencesStout, C.E.; Costantin, J.L.; Naus, C.C.; Charles, A.C. Intercellular calcium signaling in astrocytes via ATP release through connexin hemichannels. J. Biol. Chem. 2002, 277, 10482–10488. [eng
dcterms.referencesAnselmi, F.; Hernandez, V.H.; Crispino, G.; Seydel, A.; Ortolano, S.; Roper, S.D.; Kessaris, N.; Richardson, W.; Rickheit, G.; Filippov, M.A.; et al. ATP release through connexin hemichannels and gap junction transfer of second messengers propagate Ca2+ signals across the inner ear. Proc. Natl. Acad. Sci. USA 2008, 105, 18770–18775.eng
dcterms.referencesVillarroya, F.; Cereijo, R.; Villarroya, J.; Giralt, M. Brown adipose tissue as a secretory organ. Nat. Rev. Endocrinol. 2017, 13, 26–35. [eng
dcterms.referencesHull, D.; Segall, M.M. Distinction of brown from white adipose tissue. Nature 1966, 212, 469–472.eng
dcterms.referencesBerry, D.C.; Stenesen, D.; Zeve, D.; Graff, J.M. The developmental origins of adipose tissue. Development 2013, 140, 3939–3949.eng
dcterms.referencesBerry, D.C.; Stenesen, D.; Zeve, D.; Graff, J.M. The developmental origins of adipose tissue. Development 2013, 140, 3939–3949.eng
dcterms.referencesAzarnia, R.; Russell, T.R. Cyclic AMP effects on cell-to-cell junctional membrane permeability during adipocyte differentiation of 3T3-L1 fibroblasts. J. Cell Biol. 1985, 100, 265–269.eng
dcterms.referencesUmezawa, A.; Hata, J. Expression of gap-junctional protein (connexin 43 or alpha 1 gap junction) is down-regulated at the transcriptional level during adipocyte differentiation of H-1/A marrow stromal cells. Cell Struct. Funct. 1992, 17, 177–184eng
dcterms.referencesYanagiya, T.; Tanabe, A.; Hotta, K. Gap-junctional communication is required for mitotic clonal expansion during adipogenesis. Obesity Silver Spring 2007, 15, 572–582.eng
dcterms.referencesYeganeh, A.; Stelmack, G.L.; Fandrich, R.R.; Halayko, A.J.; Kardami, E.; Zahradka, P. Connexin 43 phosphorylation and degradation are required for adipogenesis. Biochim. Biophys. Acta 2012, 1823, 1731–1744.eng
dcterms.referencesYamanouchi, K.; Yada, E.; Ishiguro, N.; Nishihara, M. 18alpha-glycyrrhetinic acid induces phenotypic changes of skeletal muscle cells to enter adipogenesis. Cell. Physiol. Biochem. 2007, 20, 781–790.eng
dcterms.referencesSchiller, P.C.; D’Ippolito, G.; Brambilla, R.; Roos, B.A.; Howard, G.A. Inhibition of gap-junctional communication induces the trans-differentiation of osteoblasts to an adipocytic phenotype in vitro. J. Biol. Chem. 2001, 276, 14133–14138.eng
dcterms.referencesChen, J.; Li, L.; Li, Y.; Liang, X.; Sun, Q.; Yu, H.; Zhong, J.; Ni, Y.; Chen, J.; Zhao, Z.; et al. Activation of TRPV1 channel by dietary capsaicin improves visceral fat remodeling through connexin43-mediated Ca2+ influx. Cardiovasc. Diabetol. 2015, 14, 22.eng
dcterms.referencesTurovsky, E.A.; Varlamova, E.G.; Turovskaya, M.V. Activation of Cx43 hemichannels induces the generation of Ca2+ oscillations in white adipocytes and stimulates lipolysis. Int. J. Mol. Sci. 2021, 22, 8095.eng
dcterms.referencesShao, Q.; Esseltine, J.L.; Huang, T.; Novielli-Kuntz, N.; Ching, J.E.; Sampson, J.; Laird, D.W. Connexin 43 is dispensable for Early stage human mesenchymal stem cell adipogenic differentiation but is protective against cell senescence. Biomolecules 2019, 9, 474. [eng
dcterms.referencesMannino, G.; Vicario, N.; Parenti, R.; Giuffrida, R.; Lo Furno, D. Connexin expression decreases during adipogenic differentiation of human adipose-derived mesenchymal stem cells. Mol. Biol. Rep. 2020, 47, 9951–9958.eng
dcterms.referencesZappitelli, T.; Chen, F.; Moreno, L.; Zirngibl, R.A.; Grynpas, M.; Henderson, J.E.; Aubin, J.E. The G60S connexin 43 mutation activates the osteoblast lineage and results in a resorption-stimulating bone matrix and abrogation of old-age-related bone loss. J. Bone Miner. Res. 2013, 28, 2400–2413. [eng
dcterms.referencesZhu, Y.; Gao, Y.; Tao, C.; Shao, M.; Zhao, S.; Huang, W.; Yao, T.; Johnson, J.A.; Liu, T.; Cypess, A.M.; et al. Connexin 43 mediates white adipose tissue Beiging by facilitating the propagation of sympathetic neuronal signals. Cell Metab. 2016, 24, 420–433. [eng
dcterms.referencesThyagarajan, B.; Foster, M.T. Beiging of white adipose tissue as a therapeutic strategy for weight loss in humans. Horm. Mol. Biol. Clin. Investig. 2017, 31, 28672737. [eng
dcterms.referencesBurke, S.; Nagajyothi, F.; Thi, M.M.; Hanani, M.; Scherer, P.E.; Tanowitz, H.B.; Spray, D.C. Adipocytes in both brown and white adipose tissue of adult mice are functionally connected via gap junctions: Implications for Chagas disease. Microbes Infect. 2014, 16, 893–901. [eng
dcterms.referencesOguri, Y.; Kajimura, S. Cellular heterogeneity in brown adipose tissue. J. Clin. Investig. 2020, 130, 65–67eng
dcterms.referencesKim, S.N.; Kwon, H.J.; Im, S.W.; Son, Y.H.; Akindehin, S.; Jung, Y.S.; Lee, S.J.; Rhyu, I.J.; Kim, I.Y.; Seong, J.K.; et al. Connexin 43 is required for the maintenance of mitochondrial integrity in brown adipose tissue. Sci. Rep. 2017, 7, 7159.eng
dcterms.referencesBoengler, K.; Schulz, R. Connexin 43 and mitochondria in cardiovascular health and disease. Adv. Exp. Med. Biol. 2017, 982, 227–246.eng
dcterms.referencesLavie, C.J.; Pandey, A.; Lau, D.H.; Alpert, M.A.; Sanders, P. Obesity and atrial fibrillation prevalence, pathogenesis, and prognosis: Effects of weight loss and exercise. J. Am. Coll. Cardiol. 2017, 70, 2022–2035.eng
dcterms.referencesMangiafico, V.; Saberwal, B.; Lavalle, C.; Raharja, A.; Ahmed, Z.; Papageorgiou, N.; Ahsan, S. Impact of obesity on atrial fibrillation ablation. Arch. Cardiovasc. Dis. 2020, 113, 551–563. [eng
dcterms.referencesDhein, S. Role of connexins in atrial fibrillation. Adv. Cardiol. 2006, 42, 161–174. [eng
dcterms.referencesDhein, S.; Rothe, S.; Busch, A.; Rojas Gomez, D.M.; Boldt, A.; Reutemann, A.; Seidel, T.; Salameh, A.; Pfannmüller, B.; Rastan, A.; et al. Effects of metoprolol therapy on cardiac gap junction remodelling and conduction in human chronic atrial fibrillation. Br. J. Pharmacol. 2011, 164, 607–616. [eng
dcterms.referencesKato, T.; Iwasaki, Y.K.; Nattel, S. Connexins and atrial fibrillation: Filling in the gaps. Circulation 2012, 125, 203–206.eng
dcterms.referencesSaffitz, J.E.; Laing, J.G.; Yamada, K.A. Connexin expression and turnover: Implications for cardiac excitability. Circ. Res. 2000, 86, 723–728.eng
dcterms.referencesZhang, Y.; Hou, M.C.; Li, J.J.; Qi, Y.; Zhang, Y.; She, G.; Ren, Y.J.; Wu, W.; Pang, Z.D.; Xie, W.; et al. Cardiac β-adrenergic receptor activation mediates distinct and cell type-dependent changes in the expression and distribution of connexin 43. J. Cell. Mol. Med. 2010, 24, 8505–8517.eng
dcterms.referencesSaffitz, J.E.; Douglas, P. Zipes lecture. Biology and pathobiology of cardiac connexins: From cell to bedside. Heart Rhythm 2006, 3, 102–107.eng
dcterms.referencesJennings, M.M.; Donahue, J.K. Connexin remodeling contributes to atrial fibrillation. J. Atr. Fibrillation 2013, 6, 839.eng
dcterms.referencesIacobellis, G. Local and systemic effects of the multifaceted epicardial adipose tissue depot. Nat. Rev. Endocrinol. 2015, 11, 363–371.eng
dcterms.referencesRabkin, S.W. Epicardial fat: Properties, function and relationship to obesity. Obes Rev. 2007, 8, 253–261.eng
dcterms.referencesVillasante Fricke, A.C.; Iacobellis, G. Epicardial adipose tissue: Clinical biomarker of cardio-metabolic risk. Int. J. Mol. Sci. 2019, 20, 5989.eng
dcterms.referencesPacker, M. Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium. J. Am. Coll. Cardiol. 2018, 71, 2360–2372.eng
dcterms.referencesAnsaldo, A.M.; Montecucco, F.; Sahebkar, A.; Dallegri, F.; Carbone, F. Epicardial adipose tissue and cardiovascular diseases. Int. J. Cardiol. 2019, 278, 254–260.eng
dcterms.referencesLubbers, E.R.; Price, M.V.; Mohler, P.J. Arrhythmogenic substrates for atrial fibrillation in obesity. Front. Physiol. 2018, 9, 1482eng
dcterms.referencesGreif, M.; von Ziegler, F.; Wakili, R.; Tittus, J.; Becker, C.; Helbig, S.; Laubender, R.P.; Schwarz, W.; D’Anastasi, M.; Schenzle, J.; et al. Increased pericardial adipose tissue is correlated with atrial fibrillation and left atrial dilatation. Clin. Res. Cardiol. 2013, 102, 555–562. [eng
dcterms.referencesNalliah, C.J.; Bell, J.R.; Raaijmakers, A.J.A.; Waddell, H.M.; Wells, S.P.; Bernasochi, G.B.; Montgomery, M.K.; Binny, S.; Watts, T.; Joshi, S.B.; et al. Epicardial adipose tissue accumulation confers atrial conduction abnormality. J. Am. Coll. Cardiol. 2010, 76, 1197–1211.eng
dcterms.referencesAbe, I.; Teshima, Y.; Kondo, H.; Kaku, H.; Kira, S.; Ikebe, Y.; Saito, S.; Fukui, A.; Shinohara, T.; Yufu, K.; et al. Association of fibrotic remodeling and cytokines/chemokines content in epicardial adipose tissue with atrial myocardial fibrosis in patients with atrial fibrillation. Heart Rhythm 2018, 15, 1717–1727eng
dcterms.referencesVenteclef, N.; Guglielmi, V.; Balse, E.; Gaborit, B.; Cotillard, A.; Atassi, F.; Amour, J.; Leprince, P.; Dutour, A.; Clément, K.; et al. Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines. Eur. Heart J. 2015, 36, 795–805.eng
dcterms.referencesVenteclef, N.; Guglielmi, V.; Balse, E.; Gaborit, B.; Cotillard, A.; Atassi, F.; Amour, J.; Leprince, P.; Dutour, A.; Clément, K.; et al. Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines. Eur. Heart J. 2015, 36, 795–805.eng
dcterms.referencesCole, M.A.; Murray, A.J.; Cochlin, L.E.; Heather, L.C.; McAleese, S.; Knight, N.S.; Sutton, E.; Jamil, A.A.; Parassol, N.; Clarke, K. A high fat diet increases mitochondrial fatty acid oxidation and uncoupling to decrease efficiency in rat heart. Basic Res. Cardiol. 2011, 106, 447–457eng
dcterms.referencesKaram, B.S.; Chavez-Moreno, A.; Koh, W.; Akar, J.G.; Akar, F.G. Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes. Cardiovasc. Diabetol. 2017, 16, 120.eng
dcterms.referencesChung, M.K.; Martin, D.O.; Sprecher, D.; Wazni, O.; Kanderian, A.; Carnes, C.A.; Bauer, J.A.; Tchou, P.J.; Niebauer, M.J.; Natale, A.; et al. C-reactive protein elevation in patients with atrial arrhythmias: Inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001, 104, 2886–2891.eng
dcterms.referencesMarcus, G.M.; Smith, L.M.; Ordovas, K.; Scheinman, M.M.; Kim, A.M.; Badhwar, N.; Lee, R.J.; Tseng, Z.H.; Lee, B.K.; Olgin, J.E. Intracardiac and extracardiac markers of inflammation during atrial fibrillation. Heart Rhythm 2010, 7, 149–154eng
dcterms.referencesKondo, H.; Abe, I.; Gotoh, K.; Fukui, A.; Takanari, H.; Ishii, Y.; Ikebe, Y.; Kira, S.; Oniki, T.; Saito, S.; et al. Interleukin 10 treatment ameliorates high-fat diet-induced inflammatory atrial remodeling and fibrillation. Circ. Arrhythm. Electrophysiol. 2018, 11, e006040.eng
dcterms.referencesLazzerini, P.E.; Laghi-Pasini, F.; Acampa, M.; Srivastava, U.; Bertolozzi, I.; Giabbani, B.; Finizola, F.; Vanni, F.; Dokollari, A.; Natale, M.; et al. Systemic inflammation rapidly induces reversible atrial electrical remodeling: The role of interleukin-6-mediated changes in connexin expression. J. Am. Heart Assoc. 2019, 8, e011006eng
dcterms.referencesWang, Y.; Qian, Y.; Fang, Q.; Zhong, P.; Li, W.; Wang, L.; Fu, W.; Zhang, Y.; Xu, Z.; Li, X.; et al. Saturated palmitic acid induces myocardial inflammatory injuries through direct binding to TLR4 accessory protein MD2. Nat. Commun. 2017, 8, 13997. [eng
dcterms.referencesHu, Y.F.; Chen, Y.J.; Lin, Y.J.; Chen, S.A. Inflammation and the pathogenesis of atrial fibrillation. Nat. Rev. Cardiol. 2015, 12, 230–243. [eng
dcterms.referencesSletten, A.C.; Peterson, L.R.; Schaffer, J.E. Manifestations and mechanisms of myocardial lipotoxicity in obesity. J. Intern. Med. 2018, 284, 478–491.eng
dcterms.referencesMahajan, R.; Lau, D.H.; Brooks, A.G.; Shipp, N.J.; Wood, J.P.M.; Manavis, J.; Samuel, C.S.; Patel, K.P.; Finnie, J.W.; Alasady, M.; et al. Atrial fibrillation and obesity: Reverse remodeling of atrial substrate with weight reduction. JACC Clin. Electrophysiol. 2021, 7, 630–641.eng
dcterms.referencesSato, S.; Suzuki, J.; Hirose, M.; Yamada, M.; Zenimaru, Y.; Nakaya, T.; Ichikawa, M.; Imagawa, M.; Takahashi, S.; Ikuyama, S.; et al. Cardiac overexpression of perilipin 2 induces atrial steatosis, connexin 43 remodeling, and atrial fibrillation in aged mice. Am. J. Physiol. Endocrinol. Metab. 2019, 317, E1193–E1204eng
dcterms.referencesRothe, S.; Busch, A.; Bittner, H.; Kostelka, M.; Dohmen, P.M.; Mohr, F.W.; Dhein, S. Body mass index affects connexin43 remodeling in patients with atrial fibrillation. Thorac. Cardiovasc. Surg. 2014, 62, 547–553eng
dcterms.referencesAxelsen, L.N.; Calloe, K.; Braunstein, T.H.; Riemann, M.; Hofgaard, J.P.; Liang, B.; Jensen, C.F.; Olsen, K.B.; Bartels, E.D.; Baandrup, U.; et al. Diet-induced pre-diabetes slows cardiac conductance and promotes arrhythmogenesis. Cardiovasc. Diabetol. 2015, 14, 87eng
dcterms.referencesAubin, M.C.; Cardin, S.; Comtois, P.; Clément, R.; Gosselin, H.; Gillis, M.A.; Le Quang, K.; Nattel, S.; Perrault, L.P.; Calderone, A. A high-fat diet increases risk of ventricular arrhythmia in female rats: Enhanced arrhythmic risk in the absence of obesity or hyperlipidemia. J. Appl. Physiol. 2010, 108, 933–940. [eng
dcterms.referencesMeng, T.; Cheng, G.; Wei, Y.; Ma, S.; Jiang, Y.; Wu, J.; Zhou, X.; Sun, C. Exposure to a chronic high-fat diet promotes atrial structure and gap junction remodeling in rats. Int. J. Mol. Med. 2017, 40, 217–225.eng
dcterms.referencesTakahashi, K.; Sasano, T.; Sugiyama, K.; Kurokawa, J.; Tamura, N.; Soejima, Y.; Sawabe, M.; Isobe, M.; Furukawa, T. High-fat diet increases vulnerability to atrial arrhythmia by conduction disturbance via miR-27b. J. Mol. Cell. Cardiol. 2016, 90, 38–46.eng
dcterms.referencesZhong, P.; Quan, D.; Huang, Y.; Huang, H. CaMKII activation promotes cardiac electrical remodeling and increases the susceptibility to arrhythmia induction in high-fat diet-fed mice with hyperlipidemia conditions. J. Cardiovasc. Pharmacol. 2017, 70, 245–254.eng
dcterms.referencesJin, N.; Wang, Y.; Liu, L.; Xue, F.; Jiang, T.; Xu, M. Dysregulation of the renin-angiotensin system and cardiometabolic status in mice fed a long-term high-fat diet. Med. Sci. Monit. 2019, 25, 6605–6614.eng
dcterms.referencesPerdicaro, D.J.; Rodriguez Lanzi, C.; Fontana, A.R.; Antoniolli, A.; Piccoli, P.; Miatello, R.M.; Diez, E.R.; Vazquez Prieto, M.A. Grape pomace reduced reperfusion arrhythmias in rats with a high-fat-fructose diet. Food Funct. 2017, 8, 3501–3509eng
dcterms.referencesBaum, J.R.; Dolmatova, E.; Tan, A.; Duffy, H.S. Omega 3 fatty acid inhibition of inflammatory cytokine-mediated Connexin43 regulation in the heart. Front. Physiol. 2012, 3, 272eng
dcterms.referencesNoyan-Ashraf, M.H.; Shikatani, E.A.; Schuiki, I.; Mukovozov, I.; Wu, J.; Li, R.K.; Volchuk, A.; Robinson, L.A.; Billia, F.; Drucker, D.J.; et al. glucagon-like peptide-1 analog reverses the molecular pathology and cardiac dysfunction of a mouse model of obesity. Circulation 2013, 127, 74–85. [eng
dcterms.referencesYang, Y.M.; Seki, E. Global spread of a local fire: Transmission of endoplasmic reticulum stress via connexin 43. Cell Metab. 2021, 33, 229–230.eng
dcterms.referencesOzcan, U.; Yilmaz, E.; Ozcan, L.; Furuhashi, M.; Vaillancourt, E.; Smith, R.O.; Görgun, C.Z.; Hotamisligil, G.S. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 2006, 313, 1137–1140.eng
dcterms.referencesTirosh, A.; Tuncman, G.; Calay, E.S.; Rathaus, M.; Ron, I.; Tirosh, A.; Yalcin, A.; Lee, Y.G.; Livne, R.; Ron, S.; et al. Intercellular transmission of hepatic ER stress in obesity disrupts systemic metabolism. Cell Metab. 2021, 33, 319–333.e6.eng
dcterms.referencesSasaki, T.; Numano, R.; Yokota-Hashimoto, H.; Matsui, S.; Kimura, N.; Takeuchi, H.; Kitamura, T. A central-acting connexin inhibitor, INI-0602, prevents high-fat diet-induced feeding pattern disturbances and obesity in mice. Mol. Brain 2018, 11, 28.eng
oaire.versioninfo:eu-repo/semantics/publishedVersioneng

Archivos

Bloque original
Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
12_2021_GC_ART_New Insights on the Role.pdf
Tamaño:
1.61 MB
Formato:
Adobe Portable Document Format
Descripción:
PDF
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
381 B
Formato:
Item-specific license agreed upon to submission
Descripción:

Colecciones